Mediplastas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 113,825 | 93,012 | 218,878 | 150,995 | 261,435 | 361,905 | 304,118 | 392,668 |
| Profit before tax | - | - | - | - | 7,303 | 23,918 | 13,954 | 43,004 |
| Net profit | 4,275 | -4,123 | 7,673 | 1,092 | 6,924 | 20,320 | 11,790 | 36,108 |
| Equity | 18,238 | 14,115 | 21,788 | 20,218 | 27,142 | 22,356 | 19,647 | 23,934 |
| Liabilities | 13,090 | 10,214 | 10,729 | 40,619 | 24,242 | 44,016 | 60,312 | 82,873 |
| Non-current assets | 3,864 | 2,520 | 3,393 | 23,050 | 18,738 | 15,770 | 14,606 | 12,785 |
| Current assets | 27,464 | 21,809 | 29,124 | 37,787 | 32,646 | 50,602 | 65,353 | 94,022 |
| Total assets | 31,328 | 24,329 | 32,517 | 60,837 | 51,384 | 66,372 | 79,959 | 106,807 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 70,408 | 55,524 | 72,166 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -33.6% | -18.3% | +135.3% | -31.0% | +73.1% | +38.4% | -16.0% | +29.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 13.6% | -16.9% | 23.6% | 1.8% | 13.5% | 30.6% | 14.7% | 33.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 23.4% | -29.2% | 35.2% | 5.4% | 25.5% | 90.9% | 60.0% | 150.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.8% | -4.4% | 3.5% | 0.7% | 2.6% | 5.6% | 3.9% | 9.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 2.8% | 6.6% | 4.6% | 11.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.7 | 0.7 | 0.5 | 2.0 | 0.9 | 2.0 | 3.1 | 3.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 113,825 | 93,012 | 218,878 | 150,995 | 261,435 | 361,905 | 304,118 | 392,668 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Mediplastas - Social security debts
The company had no debts to Sodra
Mediplastas - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Mediplastas is: 1 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-28 | 2026-09-02 | 1.0 |
| 2026-08-07 | 2026-08-20 | 1.0 |
| 2026-08-02 | 2026-08-06 | 364.13 |
| 2026-02-28 | 2026-03-02 | 1.72 |
| 2026-02-21 | 2026-02-21 | 1.72 |
| 2025-09-19 | 2025-09-19 | 471.36 |
| 2025-06-19 | 2025-06-23 | 0.36 |
| 2025-05-01 | 2025-05-08 | 0.38 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Mediplastas, UAB (code 302547455) is a Private Limited Liability Company engaged in the wholesale of other intermediate products, except of paper rolls and paperboard. In 2025, the company generated €392.7K in revenue and €36.1K in net profit, compared with €304.1K revenue and €11.8K net profit in 2024 and €361.9K revenue and €20.3K net profit in 2023. This shows a dip in 2024 followed by a strong recovery in 2025, with profitability improving to a 9.2% net margin from 3.9% in 2024 and 5.6% in 2023. The latest year also shows solid operating efficiency, with asset turnover of 3.68x and revenue per employee of €392.7K. At the end of 2025, total assets stood at €106.8K, equity at €23.9K and liabilities at €82.9K. The equity ratio was 22.4% and the debt-to-equity ratio 3.46, indicating a balance sheet supported more by liabilities than equity. ROA was 33.8%, while return on equity was elevated due to the small equity base.